Antimicrobial evaluation of quaternary ammonium polyethyleneimine nanoparticles against clinical isolates of pathogenic bacteria

IET Nanobiotechnology

Volumn 9, Issue 6, 2015, Pages 342-348

  Ortega, Agustín ^a,b   Farah, Shady ^c   Tranque, Pedro ^d   Ocaña, Ana V ^a   Nam Cha, Syong H ^a   Beyth, Nurit ^c   Gómez Roldán, Carmen ^a   Pérez Tanoira, Ramón ^e   Domb, Abraham J ^c   Pérez Martínez, Francisco C ^a   Pérez Martínez, Juan ^a,b  

^a Complejo Hospitalario Universitario ^*  (Spain)

^b BIOTYC Foundation   (Spain)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CELL CULTURE; ESCHERICHIA COLI; NANOPARTICLES; TOXICITY;

ANTI-BACTERIAL ACTIVITY; ANTIBIOTIC-RESISTANT BACTERIA; GRAM-NEGATIVE BACTERIA; MINIMAL INHIBITORY CONCENTRATION; PATHOGENIC BACTERIUM; QUATERNARY AMMONIUM; STENOTROPHOMONAS MALTOPHILIA; THERAPEUTIC COMPOUNDS;

BACTERIA;

ANTIINFECTIVE AGENT; NANOPARTICLE; POLYETHYLENEIMINE; QUATERNARY AMMONIUM DERIVATIVE;

ANIMAL; BACTERIAL PHENOMENA AND FUNCTIONS; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; HUMAN; MATERIALS TESTING; MICROBIOLOGY; PARTICLE SIZE; PERITONITIS; SYNTHESIS; ULTRASTRUCTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MATERIALS TESTING; NANOPARTICLES; PARTICLE SIZE; PERITONITIS; POLYETHYLENEIMINE; QUATERNARY AMMONIUM COMPOUNDS;

EID: 84949565743     PISSN: 17518741     EISSN: None     Source Type: Journal    
DOI: 10.1049/iet-nbt.2014.0078     Document Type: Article

References (34)

1. van Esch, S., Krediet, R.T., Struijk, D.G.: 'Prognostic factors for peritonitis outcome', Contrib. Nephrol., 2012, 178, pp. 264-270
2. Singh, S., Khardori, N.M.: 'Intra-abdominal and pelvic emergencies', Med. Clin. North Am., 2012, 96, (6), pp. 1171-1191
3. Allahverdiyev, A.M., Kon, K.V., Abamor, E.S., Bagirova, M., Rafailovich, M.: 'Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents', Expert Rev. AntiInfect. Ther., 2011, 9, pp. 1035-1052
4. Roy, A., Gauri, S.S., Bhattacharya, M., Bhattacharya, J.: 'Antimicrobial activity of CaO nanoparticles', J. Biomed. Nanotechnol., 2013, 9, pp. 1570-1578
5. Kenawy, el-R., Worley, S.D., Broughton, R.: 'The chemistry and applications of antimicrobial polymers: a state-of-the-art review', Biomacromolecules, 2007, 8, pp.1359-1384
6. Kenawy, el-R., Abdel-Hay, F.I., El-Raheem, A., el-Shanshoury, R., el-Newehy, M. H.: 'Biologically active polymers: synthesis and antimicrobial activity of modified glycidyl methacrylate polymers having a quaternary ammonium and phosphonium groups', J. Control Release, 1998, 50, pp. 145-152
7. Tashiro, T.: 'Antibacterial and bacterium adsorbing macromolecules', Macromol. Mater. Eng., 2001, 286, pp. 63-87
8. dos Santos, C.A., Jozala, A.F., Pessoa, A., Seckler, M.M.: 'Antimicrobial effectiveness of silver nanoparticles co-stabilized by the bioactive copolymer pluronic F68', J. Nanobiotechnol, 2012, 10, p. 43
9. Fayaz, A.M., Balaji, K., Girilal, M., et al.: 'Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria', Nanomedicine, 2010, 6, pp. 103-109
10. Pérez-Martínez, F.C., Guerra, J., Posadas, I., Ceña, V.: 'Barriers to non-viral vector-mediated gene delivery in the nervous system', Pharm. Res., 2011, 28, pp. 1843-1858
11. van Vlerken, L.E., Vyas, T.K., Amiji, M.M.: 'Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery', Pharm. Res., 2007, 24, pp. 1405-1414
12. Visnapuu, M., Joost, U., Juganson, K., et al.: 'Dissolution of silver nanowires and nanospheres dictates their toxicity to Escherichia coli', Biomed. Res. Int., 2013, p. 819252
13. Farah, S., Khan, W., Farber, I., etal.: 'CrosslinkedQA-PEI nanoparticles: synthesis reproducibility, chemical modifications, and stability study', Polym. Adv. Technol, 2013, 24, pp. 446-452
14. Farah, S., Aviv, O., Laout, N., Ratner, S., Beyth, N., Domb, A.: 'Quaternary ammonium polyethylenimine nanoparticles for treating bacterial contaminated water', Colloids Surf. B, Biointerfaces, 2015, 128, pp. 614-619
15. Amsler, K., Santoro, C, Foleno, B., Bush, K., Flamm, R.: 'Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against Gram-negative and Gram-positive pathogens', J. Clin. Microbiol., 2010, 48, pp. 3353-3357
16. Ravikumar, S., Shyamala, S., Muthuraman, P., Srikumar, K.: 'Isolation, purification, and characterization of thermophilic T80 isoenzyme of xylose isomerase from the xerophyte Cereus pterogonus', Prep. Biochem. Biotechnol, 2011, 41, pp. 122-137
17. Gokulakrishnan, R., Ravikumar, S., Anandha-Raj, J.: 'In vitro antibacterial potential of metal oxide nanoparticles against antibiotic resistant bacterial pathogens', Asian Pac. J. Tropical Disease, 2012, 2, pp. 411-413
18. Monteiro, D.R., Gorup, L.F., Takamiya, A., et al.: 'The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver', Int. J. Antimicrob. Agents, 2009, 34, pp. 103-110
19. Pérez-Martínez, F.C., Carrión, B., Ceña, V.: 'The use of nanoparticles for gene therapy in the nervous system', J. Alzheimer Dis., 2012, 31, pp. 697-710
20. Jung, W.K., Koo, H.C., Kim, K.W., et al.: 'Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli', Appl. Environ. Microbiol, 2008, 74, pp. 2171-2178
21. Korani, M., Rezayat, S.M., Arbabi-Bidgoli, S.: 'Sub-chronic dermal toxicity of silver nanoparticles in guinea pig: special emphasis to heart, bone and kidney toxicities', Iran J. Pharm. Res., 2013, 12, pp. 511-519
22. Sondi, I., Salopek-Sondi, B.: 'Silver nanoparticles as antimicrobial agent: a case study on E. Coli as a model for Gram-negative bacteria', J. Colloid Interface Sci., 2004, 275, pp. 177-182
23. Schilte, M.N., Celie, J.W., Wee, P.M., Beelen, R.H., van den Born, J.: 'Factors contributing to peritoneal tissue remodeling in peritoneal dialysis', Perit. Dial. Int., 2009, 29, pp. 605-617
24. Rodrigues, A., Cabrita, A., Maia, P., Guimaraes, S.: 'Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis', Adv. Perit. Dial, 2002, 18, pp. 78-80
25. Wiggins, K.J., Craig, J.C., Johnson, D.W., Strippoli, G.F.: 'Treatment for peritoneal dialysis-associated peritonitis', Cochrane Database Syst. Rev., 2008, 1, p. CD005284
26. Nessim, S.J., Nisenbaum, R., Bargman, J.M., Jassal, S.V.: 'Microbiology of peritonitis in peritoneal dialysis patients with multiple episodes', Perit. Dial. Int., 2012, 32, pp. 316-321
27. van Diepen, A.T., Tomlinson, G.A., Jassal, S.V.: 'The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients', Clin. J. Am. Soc. Nephrol., 2012, 7, pp. 1266-1271
28. Brooke, J.S.: 'Stenotrophomonas maltophilia: an emerging global opportunistic pathogen', Clin. Microbiol. Rev., 2012, 25, pp. 2-41
29. Abbott, I.J., Slavin, M.A., Turnidge, J.D., Thursky, K.A., Worth, L.J.: 'Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment', Expert Rev. Anti Infect. Ther., 2011, 9, pp. 471-488
30. Nishio, K., Nakamura, R., Lin, X., et al.: 'Extracellular electron transfer across bacterial cell membranes via a cytocompatible redox-active polymer', Chemphyschem, 2013, 14, pp. 2159-2163
31. Schaffer, C, Messner, P.: 'The structure of secondary cell wall polymers: how Gram-positive bacteria stick their cell walls together', Microbiology, 2005, 51, pp. 643-651
32. Kettler, K., Veltman, K., van de Meent, D., van Wezel, A., Hendriks, A.J.: 'Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type', Environ. Toxicol. Chem., 2014, 33, pp. 481-492
33. Kawabata, N., Nishiguchi, M.: 'Antibacterial activity of soluble pyridinium-type polymers', Appl. Environ. Microbiol., 1988, 54, pp. 2532-2535
34. Taylor, E., Webster, T.J.: 'Reducing infections through nanotechnology and nanoparticles', Int. J. Nanomed., 2011, 6, pp. 1463-1473